4.6 Article

Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcoma

William A. Zammarrelli et al.

Summary: This study compared the survival rates of CS patients who underwent SLN biopsy with those who underwent systematic LND and found no difference in PFS or OS. SLN biopsy can detect nodal metastasis without compromising oncologic outcomes.

GYNECOLOGIC ONCOLOGY (2022)

Review Obstetrics & Gynecology

Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics

Zibi Marchocki et al.

Summary: Sentinel lymph node biopsy shows good detection rates and diagnostic accuracy in patients with high-grade endometrial cancer, suggesting it can replace complete lymphadenectomies as the standard of care for surgical staging.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Article Obstetrics & Gynecology

Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer

Blanca Segarra-Vidal et al.

Summary: A multicentric, propensity-matched study found no significant difference in oncologic outcomes between minimally invasive surgery and open surgery in high-risk endometrial cancer patients.

OBSTETRICS AND GYNECOLOGY (2021)

Article Surgery

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging

Maria C. Cusimano et al.

Summary: In women with intermediate- and high-grade endometrial cancer, sentinel lymph node biopsy (SLNB) showed a sensitivity of 96% and a negative predictive value of 99% for nodal metastasis detection. SLNB had acceptable diagnostic accuracy and improved the detection of node-positive cases compared with lymphadenectomy, suggesting it is a viable option for surgical staging in this patient population.

JAMA SURGERY (2021)

Article Oncology

The impact of sentinel lymph node sampling versus traditional lymphadenectomy on the survival of patients with stage IIIC endometrial cancer

Dimitrios Nasioudis et al.

Summary: The study found that performing sentinel lymph node biopsy alone did not have an adverse impact on survival in patients with lymph node positive endometrial cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Review Oncology

Current landscape and future perspective of sentinel node mapping in endometrial cancer

Giorgio Bogani et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)

Article Medicine, General & Internal

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

Pedro T. Ramirez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Oncology

Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Approach to Surgical Staging

Nadeem R. Abu-Rustum

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)

Article Obstetrics & Gynecology

Prognostic impact of lymphadenectomy in uterine serous cancer

H. Mahdi et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)

Article Oncology

Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

Pierluigi Benedetti Panici et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)